We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHR
4051
Braemar Hotels & Resorts
BHR
$139M
$12K ﹤0.01%
2,984
-4,954
-62% -$23.1K
BROS icon
4052
Dutch Bros
BROS
$9.09B
$12K ﹤0.01%
395
-2,567
-87% -$86.9K
BVS icon
4053
Bioventus
BVS
$1.2B
$12K ﹤0.01%
11,471
+4,590
+67% +$8.78K
BYSI icon
4054
BeyondSpring
BYSI
$34.5M
$12K ﹤0.01%
10,984
+4,564
+71% +$8.84K
CCCC icon
4055
C4 Therapeutics
CCCC
$522M
$12K ﹤0.01%
3,836
+2,339
+156% +$13.8K
CCLD icon
4056
CareCloud
CCLD
$110M
$12K ﹤0.01%
3,623
-47
-1% -$164
CDZI icon
4057
Cadiz
CDZI
$292M
$12K ﹤0.01%
2,884
-25,989
-90% -$105K
CLIR icon
4058
ClearSign Technologies
CLIR
$31.7M
$12K ﹤0.01%
1,457
-786
-35% -$5.98K
CLNN icon
4059
Clene
CLNN
$52.9M
$12K ﹤0.01%
522
+55
+12% +$1.43K
CNSP icon
4060
CNS Pharmaceuticals
CNSP
$8.07M
0
CRCT icon
4061
Cricut
CRCT
$1.21B
$12K ﹤0.01%
1,220
-7,543
-86% -$72.8K
CWB icon
4062
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.76B
$12K ﹤0.01%
+172
New +$11.5K
CX icon
4063
Cemex
CX
$16B
$12K ﹤0.01%
2,086
-5,053
-71% -$25.7K
CYN icon
4064
Cyngn
CYN
$16M
$12K ﹤0.01%
1
DBVT
4065
DBV Technologies
DBVT
$881M
$12K ﹤0.01%
723
-308
-30% -$4.56K
DLHC icon
4066
DLH Holdings
DLHC
$67.5M
$12K ﹤0.01%
+1,079
New +$12.9K
DSGN icon
4067
Design Therapeutics
DSGN
$928M
$12K ﹤0.01%
2,099
-1,142
-35% -$8.54K
DSP icon
4068
Viant Technology
DSP
$275M
$12K ﹤0.01%
2,707
+1,587
+142% +$6.86K
EHTH icon
4069
eHealth
EHTH
$39.1M
$12K ﹤0.01%
1,235
-766
-38% -$6.02K
EML icon
4070
Eastern Company
EML
$153M
$12K ﹤0.01%
631
+2
+0.3% +$42
ESGE icon
4071
iShares ESG Aware MSCI EM ETF
ESGE
$6.84B
$12K ﹤0.01%
375
+275
+275% +$8.71K
EVLV icon
4072
Evolv Technologies
EVLV
$1.05B
$12K ﹤0.01%
3,981
+1,642
+70% +$4.69K
AZIO
4073
Azio AI Holdings
AZIO
$23.1M
$12K ﹤0.01%
391
-110
-22% -$3.6K
FBIZ icon
4074
First Business Financial Services
FBIZ
$598M
$12K ﹤0.01%
380
-1,975
-84% -$67.6K
FCVT icon
4075
First Trust SSI Strategic Convertible Securities ETF
FCVT
$104M
$12K ﹤0.01%
376
-150
-29% -$4.82K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.